Biotech Rallies On Bullish Earnings

Fundamental insights via quarterly earnings statements into stocks trading OTC, no matter the tier, are always a refreshing event that allows investors to feel better in tuned with the company. While these company’s typically aren’t frequently covered by analysts from big banks, individuals can learn a ton by reading the headlines and digging through key metrics within the financial statements. Shares of Integrated Biopharma Inc. (OTCQX:INBP) rallied today after the company reported financial results for its quarter and fiscal year ended June 30, 2021. While the amount of information is rather robust, the highlights are as follows. Revenue for the quarter was $17.1 million compared to $13.5 million for the same quarter a year ago. Operating income for the quarter was $1.3 million when compared to $0.6 million. For the year, total revenue was $63.6 million, which is an increase of 20.5% YoY.

Integrated Biopharma Inc. is a pharmaceutical company which is engaged primarily in manufacturing, distributing, marketing, and sales of vitamins, nutritional supplements, and herbal products through its subsidiaries. It operates in two segments namely Contract Manufacturing and Other Nutraceutical Businesses. The company generates maximum revenue from the Contract Manufacturing segment. Geographically, it derives a majority of revenue from the United States.

Traders were bullish on the financials as the share price climbed up to $1.04/share (+10.05%) at the session high. This move could be an indication of things to come as the stock has been sliding a bit since making its 52-week high of $1.25 back in May.

To read the full story on AllPennyStocks.com, click here.